A carregar...
Does the antisecretory peptide AF-16 reduce lung oedema in experimental ARDS?
Background: Acute respiratory distress syndrome (ARDS) is an acute inflammatory condition with pulmonary capillary leakage and lung oedema formation. There is currently no pharmacologic treatment for the condition. The antisecretory peptide AF-16 reduces oedema in experimental traumatic brain injury...
Na minha lista:
| Publicado no: | Ups J Med Sci |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Taylor & Francis
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6968528/ https://ncbi.nlm.nih.gov/pubmed/31701794 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/03009734.2019.1685029 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|